All Stories

  1. Organic nanoplatforms for metallodrugs delivery: Current advances in colorectal cancer
  2. Targeting Triple-Negative Breast Cancer: A Special Focus on Phototherapy and Nanomaterials
  3. Liposomal formulations of novel metal-based complexes exhibiting high antitumor activity against melanoma
  4. Valorization of Thyme Combined with Phytocannabinoids as Anti-Inflammatory Agents for Skin Diseases
  5. Towards a Less Invasive Treatment for Head and Neck Cancer: Initial Evaluation of Gold Nanoparticle-Mediated Photothermal Therapy
  6. Gold nanoparticle-mediated photothermal therapy: Expanding the frontiers of cancer treatment and theragnostics
  7. Metabolism-targeted therapy in NSCLC – A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24)
  8. Locust bean gum (LBG) – A potential excipient for inhalation purposes: Excipient characterisation and in vitro and in vivo toxicological evaluation
  9. Novel 8-Hydroxyquinoline-Derived V(IV)O, Ni(II), and Fe(III) Complexes: Synthesis, Characterization, and In Vitro Cytotoxicity Against Tumor Cells
  10. Liposomal nanoformulations of novel copper-based complexes exhibiting antimelanoma activity – In vitro and in vivo validation
  11. A step forward on the in vitro and in vivo validation of rifabutin-loaded liposomes for the management of highly virulent MRSA infections
  12. Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. Int. J. Mol. Sci. 2021, 22, 5289
  13. Combination of gold nanoparticles with near-infrared light as an alternative approach for melanoma management
  14. Exploring the Biological Activity of Phytocannabinoid Formulations for Skin Health Care: A Special Focus on Molecular Pathways
  15. Liposomal Formulation of an Organogold Complex Enhancing Its Activity as Antimelanoma Agent—In Vitro and In Vivo Studies
  16. In Vivo Measurements of Murine Melanoma's Complex Permittivity Between 500 MHz and 8.5 GHz
  17. Gold nanoparticles for photothermal therapy – Influence of experimental conditions on the properties of resulting AuNPs
  18. 3D-printed aerogels as theranostic implants monitored by fluorescence bioimaging
  19. Combining Phototherapy and Gold-Based Nanomaterials: A Breakthrough in Basal Cell Carcinoma Treatment
  20. Rifabutin: a repurposed antibiotic with high potential against planktonic and biofilm staphylococcal clinical isolates
  21. Targeting superficial cancers with gold nanoparticles: a review of current research
  22. Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
  23. Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles
  24. Role of ionic liquids in ibuprofen-based eutectic systems: Aqueous solubility, permeability, human cytotoxicity, hemolytic activity and anti-inflammatory activity
  25. Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors
  26. An alternative hybrid lipid nanosystem combining cytotoxic and magnetic properties as a tool to potentiate antitumor effect of 5-fluorouracil
  27. A Step Forward for the Treatment of Localized Prostate Cancer Using Gold Nanoparticles Combined with Laser Irradiation
  28. Liposomal Rifabutin—A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Staphylococcus aureus Infections
  29. Liposomal Rifabutin – A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant <em>Staphylococcus aureus </em>Infections
  30. Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria
  31. Rational approach to design gold nanoparticles for photothermal therapy: the effect of gold salt on physicochemical, optical and biological properties
  32. Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability
  33. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
  34. Respirable konjac glucomannan microparticles as antitubercular drug carriers: Effects of in vitro and in vivo interactions
  35. Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma
  36. Breast Cancer Brain Metastases: Implementation and Characterization of a Mouse Model Relying on Malignant Cells Inoculation in the Carotid Artery
  37. miR‐21‐5p promotes NASH‐related hepatocarcinogenesis
  38. Cu(II) and Zn(II) Complexes of New 8-Hydroxyquinoline Schiff Bases: Investigating Their Structure, Solution Speciation, and Anticancer Potential
  39. A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma
  40. Experimental Murine Models for Colorectal Cancer Research
  41. Safety of Gold Nanoparticles: From In Vitro to In Vivo Testing Array Checklist
  42. Pluronic® F127 Hydrogel Containing Silver Nanoparticles in Skin Burn Regeneration: An Experimental Approach from Fundamental to Translational Research
  43. Advancing Medicine with Lipid-Based Nanosystems—The Successful Case of Liposomes
  44. Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches
  45. Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management
  46. Challenges in delivery of plant actives
  47. Current Insights and Progress in the Clinical Management of Head and Neck Cancer
  48. Metal Coordination and Biological Screening of a Schiff Base Derived from 8-Hydroxyquinoline and Benzothiazole
  49. 3D-MSCs A151 ODN-loaded exosomes are immunomodulatory and reveal a proteomic cargo that sustains wound resolution
  50. Nanoformulation of Seaweed Eisenia bicyclis in Albumin Nanoparticles Targeting Cardiovascular Diseases: In Vitro and In Vivo Evaluation
  51. Melanoma Management: From Epidemiology to Treatment and Latest Advances
  52. Liposomal Delivery of Newly Identified Prophage Lysins in a Pseudomonas aeruginosa Model
  53. How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT
  54. Human Cytotoxicity, Hemolytic Activity, Anti-Inflammatory Activity and Aqueous Solubility of Ibuprofen-Based Ionic Liquids
  55. Biological Thermal Performance of Organic and Inorganic Aerogels as Patches for Photothermal Therapy
  56. New iron(III) anti-cancer aminobisphenolate/phenanthroline complexes: Enhancing their therapeutic potential using nanoliposomes
  57. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model
  58. Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells
  59. Liposomes as Tools to Improve Therapeutic Enzyme Performance
  60. The Role of Rosmarinic Acid on the Bioproduction of Gold Nanoparticles as Part of a Photothermal Approach for Breast Cancer Treatment
  61. A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics
  62. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
  63. Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening
  64. Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma
  65. Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
  66. miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
  67. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
  68. A Newfangled Collagenase Inhibitor Topical Formulation Based on Ethosomes with Sambucus nigra L. Extract
  69. Development of a Topical Insulin Polymeric Nanoformulation for Skin Burn Regeneration: An Experimental Approach
  70. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance
  71. GMP-grade nanoparticle targeted to nucleolin downregulates tumor molecular signature, blocking growth and invasion, at low systemic exposure
  72. Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management
  73. Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma
  74. Gold-Based Nanoplataform for the Treatment of Anaplastic Thyroid Carcinoma: A Step Forward
  75. Ecotoxicity and Hemolytic Activity of Fluorinated Ionic Liquids
  76. Liposomes as a Nanoplatform to Improve the Delivery of Antibiotics into Staphylococcus aureus Biofilms
  77. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs
  78. Advances in nanotechnology-related strategies against melanoma
  79. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
  80. Recent Advances in Ionic Liquids and Nanotechnology for Drug Delivery
  81. A Step Forward in Breast Cancer Research: From a Natural-Like Experimental Model to a Preliminary Photothermal Approach
  82. Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations
  83. Synchronous insight of in vitro and in vivo biological activities of Sambucus nigra L. extracts for industrial uses
  84. Preliminary Assays towards Melanoma Cells Using Phototherapy with Gold-Based Nanomaterials
  85. mIR-21 is increased in patients with NASH-associated HCC and contributes to hepatocarcinogenesis in mice with NAFLD
  86. Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors
  87. How Can Biomolecules Improve Mucoadhesion of Oral Insulin? A Comprehensive Insight using Ex-Vivo, In Silico, and In Vivo Models
  88. A Novel Hybrid Nanosystem Integrating Cytotoxic and Magnetic Properties as a Tool to Potentiate Melanoma Therapy
  89. The Aquaporin-3-Inhibiting Potential of Polyoxotungstates
  90. If you cannot beat them, join them: Exploring the fruits of the invasive species Carpobrotus edulis (L.) N.E. Br as a source of bioactive products
  91. Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection
  92. Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells
  93. Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease
  94. Emergent Nanotechnological Strategies for Systemic Chemotherapy against Melanoma
  95. Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
  96. 11th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies
  97. Abstracts of the 55th Congress of the European Societies of Toxicology (EUROTOX 2019) TOXICOLOGY SCIENCE PROVIDING SOLUTIONS
  98. Demonstrating the Safety of Nanoparticles with Persimmon Extract
  99. FRI-278-RIP3-dependent signalling exerts divergent effects on liver steatosis and carcinogenesis in experimental non-alcholic fatty liver disease
  100. Copper Complex Nanoformulations Featuring Highly Promising Therapeutic Potential in Murine Melanoma Models
  101. New Hyaluronic Acid Particles for Longer-Lasting Osteoarthritis Relief
  102. The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis
  103. Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
  104. Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer
  105. α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma
  106. Track analysis of the passage of rhodamine-labeled liposomes across porcine jejunal mucus in a microchannel device
  107. The role of necroptosis in non-alcoholic fatty liver disease-related carcinogenesis
  108. RIP3-dependent signalling contributes to non-alcoholic fatty liver disease-related hepatocarcinogenesis
  109. miRNA-21 ablation protects against liver injury and necroptosis in cholestasis
  110. Lipid Vesicles for Skin Delivery: Evolution from First Generation
  111. Lipid-Based Nanocarriers for the Treatment of Infected Skin Lesions
  112. Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery
  113. The selective cytotoxicity of new triazene compounds to human melanoma cells
  114. Umbilical cord tissue–derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing
  115. Lipid-Based Nanocarriers for Cutaneous Leishmaniais and Buruli Ulcer Management
  116. Activation of necroptosis in human and experimental cholestasis
  117. Nanoformulations of a Potent copper-based Aquaporin Inhibitor With Cytotoxic Effect Against Cancer Cells
  118. Nanoformulations of a Triazene Analogue with Specific Affinity to Human Melanoma
  119. Lipid-Based Nanoformulations of Trifluralin Analogs in the Management ofLeishmania InfantumInfections
  120. Human neonatal mesenchymal stem cell spheroids-conditioned medium accelerates skin regeneration
  121. Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems
  122. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing
  123. In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model
  124. What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?
  125. Liposomes versus Lipid Nanoparticles: Comparative Study of Lipid-Based Systems as Oryzalin Carriers for the Treatment of Leishmaniasis
  126. The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis
  127. Targeted Delivery of Transferrin-Conjugated Liposomes to an Orthotopic Model of Lung Cancer in Nude Rats
  128. Synthesis, stability, biochemical and pharmacokinetic properties of a new potent and selective 4-oxo-β-lactam inhibitor of human leukocyte elastase
  129. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers
  130. Atomic Force Microscopy for the Characterization of Proteoliposomes
  131. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H37Rv, MDR and NRP Mycobacterium tuberculosis
  132. Inhaled Liposomes–Current Strategies and Future Challenges
  133. Developments on Drug Delivery Systems for the Treatment of Mycobacterial Infections
  134. Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis
  135. Radiation sterilization of antibiotic liposome formulations: A case study
  136. Enzymosomes with surface-exposed superoxide dismutase: In vivo behaviour and therapeutic activity in a model of adjuvant arthritis
  137. Liposomal Superoxide Dismutases and Their Use in the Treatment of Experimental Arthritis
  138. Design and characterization of enzymosomes with surface-exposed superoxide dismutase
  139. Therapeutic Efficacy of Liposomal Rifabutin in a Mycobacterium avium Model of Infection
  140. Formulation of l-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release
  141. Biological characterization of L -asparaginase liposomal formulations
  142. Liposomal l-asparaginase: in vitro evaluation